UBE4B
Basic information
Region (hg38): 1:10032832-10181239
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UBE4B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 50 | 52 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 52 | 4 | 5 |
Variants in UBE4B
This is a list of pathogenic ClinVar variants found in the UBE4B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-10033703-G-T | Likely benign (Mar 28, 2018) | |||
1-10072095-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
1-10072145-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
1-10072183-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
1-10095464-T-G | not specified | Uncertain significance (Nov 12, 2021) | ||
1-10095509-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
1-10101105-A-C | Benign (Dec 31, 2019) | |||
1-10101206-G-A | Likely benign (Jan 01, 2023) | |||
1-10101207-A-G | Likely benign (Jan 01, 2023) | |||
1-10102980-G-C | not specified | Uncertain significance (Oct 20, 2023) | ||
1-10103090-A-G | not specified | Uncertain significance (Aug 16, 2021) | ||
1-10105522-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
1-10105554-A-T | not specified | Uncertain significance (Oct 20, 2023) | ||
1-10105569-A-T | not specified | Uncertain significance (Jun 18, 2021) | ||
1-10105570-T-C | not specified | Uncertain significance (Oct 04, 2022) | ||
1-10105726-G-T | not specified | Uncertain significance (Oct 17, 2023) | ||
1-10106259-C-T | not specified | Uncertain significance (May 23, 2023) | ||
1-10106280-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
1-10106318-A-G | not specified | Uncertain significance (May 24, 2023) | ||
1-10106370-C-T | not specified | Uncertain significance (May 27, 2022) | ||
1-10106409-C-T | not specified | Uncertain significance (Nov 22, 2021) | ||
1-10106438-C-T | not specified | Uncertain significance (Jun 21, 2021) | ||
1-10106444-C-A | not specified | Uncertain significance (Apr 26, 2023) | ||
1-10106447-C-G | not specified | Uncertain significance (Dec 02, 2022) | ||
1-10106459-A-G | not specified | Uncertain significance (Jun 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UBE4B | protein_coding | protein_coding | ENST00000343090 | 28 | 148408 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 9.02e-8 | 125597 | 0 | 150 | 125747 | 0.000597 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.73 | 488 | 781 | 0.625 | 0.0000471 | 8556 |
Missense in Polyphen | 68 | 197.64 | 0.34406 | 2086 | ||
Synonymous | 0.677 | 284 | 299 | 0.950 | 0.0000188 | 2554 |
Loss of Function | 7.02 | 5 | 67.0 | 0.0747 | 0.00000358 | 763 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000151 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000264 | 0.000231 |
European (Non-Finnish) | 0.00127 | 0.00119 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000880 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases (By similarity). May also function as an E4 ligase mediating the assembly of polyubiquitin chains on substrates ubiquitinated by another E3 ubiquitin ligase (By similarity). May regulate myosin assembly in striated muscles together with STUB1 and VCP/p97 by targeting myosin chaperone UNC45B for proteasomal degradation (PubMed:17369820). {ECO:0000250|UniProtKB:P54860, ECO:0000250|UniProtKB:Q9ES00, ECO:0000269|PubMed:17369820}.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);Protein processing in endoplasmic reticulum - Homo sapiens (human);p73 transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.283
- rvis_EVS
- -1.39
- rvis_percentile_EVS
- 4.31
Haploinsufficiency Scores
- pHI
- 0.388
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.614
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.788
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ube4b
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein polyubiquitination;ventricular trabecula myocardium morphogenesis;ubiquitin-dependent protein catabolic process;protein monoubiquitination;granzyme-mediated apoptotic signaling pathway;response to UV;ubiquitin-dependent ERAD pathway;neuron projection development;proteasome-mediated ubiquitin-dependent protein catabolic process;protein autoubiquitination
- Cellular component
- ubiquitin ligase complex;nucleus;cytoplasm
- Molecular function
- ATP binding;enzyme binding;ubiquitin-ubiquitin ligase activity;ATPase binding